Sep 11, 2013 ... of Arkansas in favor of St. Jude Medical, Inc. and St. Jude. Medical Puerto Rico, LLC ... to Janzen et al. (the Janzen patent or '439 .... St. Jude. Med., Inc. v. Access Closure, Inc., 08-CV-4101, 2011 WL. 5374424, at *4 (W.D. Ark.
Sep 12, 2013 ... Access Closure Inc. Unlike earlier decisions regarding whether ... double patenting carved out by 35 U.S.C. § 121 in St. Jude Medical, Inc. v.
Sep 23, 2013 ... In the recent Federal Circuit case of St. Jude Medical v. Access Closure, the defendant Access Closure, Inc. (ACI) appealed several rulings made by the United States District Court ... 7,008,439 to Janzen et al., U.S. Patent No.
Jun 30, 2016 ... Plaintiff, a holder of common stock of St. Jude Medical, Inc. (“St. Jude” or the .... pacemakers, electrophysiology catheters, vascular closure products, ...... provided with or had unlimited access to copies of the Registration ...
access site hemostasis is important. ... Angio-Seal (St. Jude Medical, Inc., St. Paul , MN) continues .... (4.4 minutes vs 20.1 minutes and 2.5 hours vs 6.2 hours,.
Sep 24, 2013 ... Access Closure Inc., the Federal Circuit recently reversed a ruling that claims in a first sibling ... There are four related patents owned by St. Jude Medical Inc. and St. Jude Medical ... all three patents (the grandparent patent, the Janzen patent and the sibling patent) had ... The case is St. Jude Medical Inc. v.
Nov 1, 2016 ... (1)First Department of Medicine, University Medical Center ... patients either treated by a specific FC (Angio-Seal™, St. Jude Medical, Inc., St. ... Most common type of access site bleeding consisted of hematomas (FC 45% vs.
A summary of the arterial closure devices that are currently available for clinical ... for repeated access into vessels while maintaining intraprocedural hemostasis and ... the VasoSeal device (St. Jude, Medical, Inc., St. Paul, MN) was approved for .... which demonstrated no difference in major vascular complications (2.1% vs ...
May 24, 2016 ... St. Jude Medical, Inc. Circulatory System ... percutaneous, transcatheter closure of a PFO to .... Insufficient data on anticoagulant vs. antiplatelet therapy1 ..... Access site bleeding (1 required a stitch, 1 required transfusion,.